Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2011, Vol. 16 ›› Issue (12): 1410-1413.

Previous Articles     Next Articles

Effection of Shenmai Injection for chemotherapy patients with cancer on blood tests and CD4/CD8 ratio

ZHOU Yue-fen , WU Min-hua, CHEN Xue-feng, YIN Xiao-li , XIE Yan-ru, WANG Yong-hui, LOU Jian   

  1. Oncology Department, the 5th Affiliated Hospital of Wenzhou Medical College ,the Central Hospital of Lishui City, Lishui 323000, Zhejiang, China
  • Received:2011-10-05 Revised:2011-11-11 Online:2011-12-26 Published:2012-01-07

Abstract: AIM: To study the effect of Shenmai Injection for gastrointestinal tumor patients after operation with oxaliplatin chemotherapy on blood tests and CD4/CD8 level.METHODS: Eighty cases of gastrointestinal tumor patients after operation with oxaliplatin chemotherapy were divided into single group and combined group, each 40 cases. The single group was administered by chemotherapy only while the combined group by chemotherapy and Shenmai Injection. After 6 cycle chemotherapy, TCM symptoms integral, neutrophils, CD4/CD8 ratio were compared between two groups.RESULTS: Compared with the single group, the TCM symptoms integral of the combined group was less (P<0.01). Compared with the single group, the neutrophils level of the combined group was less (P<0.05). Compared with the single group, the CD4 level and CD4/CD8 ratio were more and statistically significant (P<0.05).CONCLUSION: Shenmai Injection can improve chemotherapy related symptoms and reduce bone marrow toxicity; it can also adjust chemotherapy patient's immune status and ensure chemotherapy smoothly.

Key words: Shenmai Injection, Tumor, Blood routine, CD4/CD8

CLC Number: